On March 19, 2025, China’s State Council unveiled the Regulations on Handling Foreign-Related Intellectual Property Disputes (hereinafter referred to as the "Regulations"), which will take effect on May 1.
On January 6, 2025, the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO), which is responsible for patent invalidation hearings, issued its final results of the IPR (Inter Partes Reviews) of BOE's challenge to two Samsung Display patents. The results
On 3 January, a wholly-owned subsidiary of Jinko Solar Co., Ltd. ("JinkoSolar"), filed a lawsuit against LONGi Green Energy Technology Co., Ltd. (“LONGi”), requesting the latter to immediately stop infringing the invention patents related to TOPCon technology and to compensa
Two recent announcements have put Delta-like ligand 3 (DLL3), a high-potential target, into the spotlight. Both Hengrui Pharma and Innovent's ADC innovative drugs were licensed out for more than US$1 billion. DLL3Antibody–drug conjugates or ADCs are a class of biopharmaceutical drugs design
Photo: TP-LINKOn December 18th 2024, The Wall Street Journal reported that the US government is studying the possibility of banning Chinese network router companies from selling TP-Link products in the US for fear that TP-Link might be involved in cyber-attacks by Chinese hackers
